Aging disrupts cell subpopulation dynamics and diminishes the function of mesenchymal stem cells
Citations Over TimeTop 10% of 2014 papers
Abstract
Advanced age is associated with an increased risk of vascular morbidity, attributable in part to impairments in new blood vessel formation. Mesenchymal stem cells (MSCs) have previously been shown to play an important role in neovascularization and deficiencies in these cells have been described in aged patients. Here we utilize single cell transcriptional analysis to determine the effect of aging on MSC population dynamics. We identify an age-related depletion of a subpopulation of MSCs characterized by a pro-vascular transcriptional profile. Supporting this finding, we demonstrate that aged MSCs are also significantly compromised in their ability to support vascular network formation in vitro and in vivo. Finally, aged MSCs are unable to rescue age-associated impairments in cutaneous wound healing. Taken together, these data suggest that age-related changes in MSC population dynamics result in impaired therapeutic potential of aged progenitor cells. These findings have critical implications for therapeutic cell source decisions (autologous versus allogeneic) and indicate the necessity of strategies to improve functionality of aged MSCs.
Related Papers
- → Tumor Angiogenesis, Vascularization, and Contrast-Enhanced Magnetic Resonance Imaging(1999)59 cited
- Angiogenesis in cancer.(1997)
- → An In Vivo Angiogenesis Assay to Study Positive and Negative Regulators of Neovascularization(2003)4 cited
- → Modulation of Angiogenesis: Experimental Strategies and Potential Therapeutic Applications(2003)2 cited
- The roles of endothelial progenitor cells in tumor neovascularization(2012)